Driving innovation and transforming
healthcare in Peru

Our Approach

To be innovative, overcoming every challenge that comes
with it, in order to
become a benchmark in
healthcare across Latin
America.

We transform healthcare with innovation and commitment.

Since 2005, we have developed and provided advanced therapies in oncology, hematology, infectious diseases, and multiple medical specialties, including rare and orphan diseases. Our approach is grounded in clinical research, timely access, and therapeutic quality, offering healthcare professionals effective solutions aligned with international standards of safety and efficacy.

Our Vision

To be a benchmark company in the Peruvian healthcare sector, recognized for its management capacity, constant innovation, and commitment to access to high-value therapies…

Our Mision

To continuously contribute to improve the quality of life of patients in Peru through the responsible and timely import and distribution of…


Our Values

Compliance,
Punctuality and respect,
Customer orientation, Responsibility and commitment, Development and innovation, Ongoing training...

We offer products for various therapeutic specialties, such as oncology, hematology, and infectiology, as well as rare diseases; in addition to cell therapies and other pharmaceutical services. Our commitment is to provide safe, effective, and high-quality medicines; support physicians with innovative therapies, and facilitate patient access to cutting-edge treatments.

Dr. Leopoldo Valdez Castañeda

CEO Global Med Farma

Achievements that inspire and drive
us to keep moving forward

We have successfully laid the foundation for today’s new national programs.

Throughout our experience, at Global Med Farma we have driven concrete advances in public health—from supplying factors for the treatment of hemophilia, to providing specialized technology for pediatric transplants, and incorporating therapies for rare diseases. We are proud of these achievements, which reflect our sustained commitment to delivering solutions that transform patient health in Peru.

0

Burosumab

In 2022, we introduced Crysvita® to the Peruvian market, the first and only monoclonal antibody in the world approved for the treatment of Hypophosphatemia...

+0

Transplants

More than 72 haploidentical transplants in pediatric patients with
unrelated donors were made possible
thanks to our cell separation
products...

+0

Supplying

For more than 7 years, we were
pioneers in supplying coagulation
factors for the prophylactic treatment
of hemophilia A and B in public institutions...

Consulting, Outsourcing,
and Business Development
Services

Through its Pharma Business Outsourcing unit, Global Med Farma provides consulting, outsourcing, and business development services for the pharmaceutical industry in Latin America and beyond. Our Executive Team brings extensive experience in managing pharmaceutical businesses in the region, across both multinational corporations and regionally focused companies.

Our Units and
Services

We offer a wide range of products and services
distributed across different units

Medical
Specialties
Unit

Our highly specialized products meet the
medical needs of
patients.

Medical
Orphan
Diseases Unit

Providing the opportunity to
access the most advanced
therapies in a timely manner.


Research
Unit

We have always focused
on improving patients’
lives through highly
effective and safe
therapies.

Unavailable Medicine Access Unit

We work constantly to transform patients’ lives through innovative and safe treatments.

Pharma
Business
Outsourcing

Through the PBO Business Unit, we provide Consulting, Outsourcing, and Business Development services.

Innovating and delivering

the best solutions
in medical research

We have the leading research laboratory
in Latin America.

×

Before sending your message, please read this.

Pharmacovigilance is the science and activities related to the detection, assessment, understanding, and prevention of adverse reactions or any other health problem associated with medicines or vaccines.

Pharmacovigilance seeks to ensure that the benefit-risk balance remains favorable throughout the entire life cycle of a medicine, that is, from the time it is authorized until it is withdrawn from the market or its production is discontinued.

Pharmacovigilance seeks to ensure that the benefit-risk balance remains favorable throughout the entire life cycle of a medicine, that is, from the time it is authorized until it is withdrawn from the market or its production is discontinued.

Pharmacovigilance involves various public health activities of risk analysis and management that contribute to the rational use of medicines.

Buscar contenido